Shire Announces Launch of FOSRENOL(R) in Japan

DUBLIN - Availability of Non-Calcium, Non-Resin FOSRENOL(R) Gives New
Therapy Choice for the Management of Hyperphosphataemia in End-Stage Renal
Disease Patients(1) in Japan

Medical Insurance Coverage in Africa a Possible Key to Improved Healthcare Access, States Frost & Sullivan

CAPE TOWN, South Africa - The medical insurance industry in key Sub-Saharan African countries such
as Kenya, Tanzania, Ghana, Zambia, and Malawi is currently in an
introductory-to-medium growth stage. There is, however, an increasing level
of awareness of the benefits of medical insurance cover among members of the

Thomson Reuters Publishes Pharma Matters White Paper, ‘The Five Myths of Generic Competition’

PHILADELPHIA and LONDON - Unique Survey Shows Much Room for Originator Pharmaceutical Companies
to Improve Their Understanding of Generic Competition

Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease

EINDHOVEN, The Netherlands - The Center for Translational Molecular Medicine (CTMM) - the Dutch
public-private partnership committed to the research and development of new
techniques for the diagnosis and treatment of major diseases - today
announced that eight new research projects will receive funding from the
CTMM. It means that almost 250 million Euros have now been allocated to
Netherlands-based translational projects that could radically improve patient
outcomes for diseases such as Alzheimer’s, rheumatoid arthritis, sepsis,
cardiovascular disorders and the most important forms of cancer.

Protected by Comment Guard Pro